申请人:——
公开号:US20030045568A1
公开(公告)日:2003-03-06
Thiosemicarbazone compounds of formula:
1
are useful for treating infection by the hepatitis C virus, treating hepatitis C or a related condition, delaying the onset of hepatitis C or a related condition, preventing hepatitis C or a related condition, and inhibiting replication of the hepatitis C virus. In the formula Q is
2
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
, and R
13
, are substituents as defined herein, and m, t, u, v, w, x and y are integers as defined herein.
式中的硫代氨基甲酸化合物:
1
可用于治疗丙型肝炎病毒感染、治疗丙型肝炎或相关疾病、延缓丙型肝炎或相关疾病的发作、预防丙型肝炎或相关疾病以及抑制丙型肝炎病毒的复制。式中 Q 为
2
其中 R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
和 R
13
是本文定义的取代基,m、t、u、v、w、x 和 y 是本文定义的整数。